| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Omega Fund VI, L.P. | Former 10% owner | $109M | Jul 20, 2021 | ||
| Clarus Lifesciences III, L.P. | 10%+ Owner | $85.5M | Mar 30, 2022 | ||
| Patrick J. Heron | Director | $83.2M | Jul 20, 2021 | ||
| Wan-Jen Hong | Chief Medical Officer | $36K | Jul 18, 2022 | ||
| Enoch Kariuki | Director | Jan 11, 2023 | |||
| Hugh Rienhoff JR | Chief Executive Officer, Director | Jan 11, 2023 | |||
| Jennifer Peppe | Global Head, Clinical Operations | Jan 11, 2023 | |||
| Laura G. Eichorn | Chief Financial Officer | Jan 11, 2023 | |||
| Dennis Henner | Director | Jan 11, 2023 | |||
| Robert Baltera | Director | Jan 11, 2023 | |||
| Hsiangyi Chiang | Senior Vice President, Finance | Jan 11, 2023 | |||
| Laurie Keating | Director | Jan 11, 2023 | |||
| Matthew Plunkett | Chief Financial Officer | Jul 15, 2021 | |||
| Amy E. Tapper | Chief, Technical Operations | Jan 11, 2023 | |||
| Dina Chaya | Director | Jan 11, 2023 | |||
| Michael Arenberg | Chief Operating and Business Officer | Jan 11, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|